GLP-1 Coverage Gutted in 2027 MHBP Standard Plan
The 2027 MHBP Standard plan changes GLP-1 weight-loss drug coverage from 2026's 30% coinsurance with a $200 cap to 50% coinsurance with no cap, leading a user to estimate out-of-pocket costs of $600–700 per month. Several federal employees on Reddit report that multiple FEHB plans are raising GLP-1 cost sharing for 2027, but Novo Nordisk has announced a reduction in Wegovy's list price, so the actual impact may be smaller than the estimate.
Original post by u/MrWookieMustache in r/fednews stating that the MHBP standard plan's 2027 GLP-1 weight-loss drug coverage will change from 2026's "30% coinsurance, $200 cap" to "50% coinsurance, no cap," with an estimated out-of-pocket cost of possibly $600–700/month. Multiple federal employees (u/HappyManagement9728, u/JustMe39908, u/NoSupermanMD) confirmed that several FEHB plans are simultaneously raising GLP-1 out-of-pocket costs for 2027, while u/SplooshU and u/gigglesandshit4brain and others pointed out that Novo Nordisk has announced a cut to Wegovy's list price, so the actual impact may be smaller than the post's estimate. On the factual level, the MHBP 2027 plan lists weight-loss drugs at 50% plan coinsurance (✔ verified); however, "no cap leading to $600–700/month" is a user's calculation, not an official figure.
Checked ✔ (The MHBP 2027 plan's "50% coinsurance, no cap" verified via the plan brochure; the specific monthly out-of-pocket amount is a user's calculation, not an officially published figure)
Reddit discussion traction: 407 upvotes and 222 comments
Source: Reddit